Flora Peyvandi/X
Nov 21, 2025, 06:09
Flora Peyvandi: Factor IX-Padua AAV Gene Therapy in Hemophilia B
Flora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of ISTH, shared a post on X:
“Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials in China”
Title: Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials
Authors: Feng Xue, Mankai Ju, Tienan Zhu, Zeping Zhou, Jing Sun, Linhua Yang, Zhenyu Yan, Hu Zhou, Xin Du, ChangCheng Zheng, Jing Zheng, Xia Wu, Zengmin Du, Wei Jiang, Caifeng Yang, Xiao Xiao, Wei Liu, Renchi Yang and Lei Zhang.
Read the full article on nature medicine.
Find more posts featuring Flora Peyvandi on Hemostasis Today.
-
Oct 10, 2026, 10:07Maha Othman: Look Forward to an Amazing ISTH 2027 in Vancouver!
-
Oct 10, 2026, 10:02Rucha Patil: National Convening Highlights Opportunities for Equitable Hemophilia Care Across India
-
Oct 10, 2026, 09:52Yuria Ito: Should Ferritin Testing Become a Routine Part of Prenatal Care in Japan?
-
Oct 10, 2026, 09:48Ahmed Alotaibi: Can We “Remove” the ABO Problem from Group O Platelets?
-
Oct 10, 2026, 09:31Help Shape the New ASH Iron Deficiency Guidelines – American Society of Hematology
-
Oct 10, 2026, 09:05Wolfgang Miesbach: Moving from Bleed Control to Comprehensive Joint Health
-
Oct 10, 2026, 07:59Leila Caroline Souza Reis: Enoxaparin Dosing for VTE Prevention in Adults With Obesity
-
Oct 10, 2026, 07:41Adeeb Bazuhair: New Evidence for Catheter Directed Thrombolysis in Acute PE
-
Oct 10, 2026, 07:22Poppy Clarke: Turning Steps Into Support for Thrombosis Awareness